Amarin Corporation plc (AMRN)

Etorro trading 970x250
Amarin Corporation plc (AMRN) Logo

About Amarin Corporation plc

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Grand Canal Docklands, Dublin, Ireland, 2

Amarin Corporation plc News and around…

Latest news about Amarin Corporation plc (AMRN) common stock and company :

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021 - AMRN
26 Nov, 2021 Yahoo! Finance

New York, New York--(Newsfile Corp. - November 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Amarin Corporation Plc ("Amarin") (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more ...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation PLC, of Class Action Lawsuit and Upcoming Deadline - AMRN
26 Nov, 2021 Yahoo! Finance

Pomerantz LLP announces that a class action lawsuit has been filed against Amarin Corporation PLC ("Amarin" or the "Company") (NASDAQ: AMRN) and certain of its officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 21-cv-19911, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Amarin securities between December 5, 2018 and June 21, 2021, inclusive (the "Class

AMRN, BMRN & RECAF - Upcoming Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC
25 Nov, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / November 25, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.

Levi & Korsinsky, LLP, Researching Possible Securities Law Violations - Amarin Corporation Plc -AMRN
24 Nov, 2021 Yahoo! Finance

The following statement is being issued by Levi & Korsinsky, LLP:

January 2022 Options Now Available For Amarin
24 Nov, 2021 FinancialContent

Investors in Amarin Corp plc (AMRN) saw new options begin trading today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for the new January 2022 contracts and identified one put and one call contract of particular interest.

LAWSUITS FILED AGAINST AMRN, CEI and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
22 Nov, 2021 FinancialContent
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HEPS, AMRN and FB
19 Nov, 2021 FinancialContent
AMRN LOSS ALERT: Rosen, Top Ranked Investor Counsel, Encourages Amarin Corporation plc Investors with Losses OVER $ 100K to Secure Counsel Before Important Deadline in Class Action - AMRN
19 Nov, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / November 19, 2021 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ:AMRN) between December 5, 2018 and June 21, 2021, inclusive (the "Class Period") of the important December 23, 2021 lead plaintiff deadline.SO WHAT: If you purchased Amarin securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra

CLASS ACTION UPDATE for BMRN, AMRN and Z: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
19 Nov, 2021 FinancialContent
AMRN, BMRN & RECAF – Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC
19 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as le

Lawsuits Filed Against AMRN, RECAF and HMLP - Jakubowitz Law Pursues Shareholders Claims
19 Nov, 2021 FinancialContent
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX
18 Nov, 2021 FinancialContent
Rosen, Top Ranked Investor Counsel, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMRN
18 Nov, 2021 Yahoo! Finance

New York, New York--(Newsfile Corp. - November 18, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021, inclusive (the "Class Period") of the important December 23, 2021 lead plaintiff deadline.SO WHAT: If you purchased Amarin securities during the Class Period you may be entitled to compensation without payment of any out ...

CLASS ACTION UPDATE for INNV, ZEV and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
18 Nov, 2021 FinancialContent
SHAREHOLDER ALERT: AMRN CEI SNAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
17 Nov, 2021 FinancialContent
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
17 Nov, 2021 Yahoo! Finance

WHY: NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5, 2018 and June 21, 2021, inclusive (the “Class Period”) of the important December 23, 2021 lead plaintiff deadline. SO WHAT: If you purchased Amarin securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AMRN, HMLP and ONTF
17 Nov, 2021 FinancialContent
AMRN, BMRN & RECAF - Class Actions: Bronstein, Gewirtz & Grossman, LLC
17 Nov, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / November 17, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.

Here’s 3 Penny Stocks You Need to Know About Today
17 Nov, 2021 FinancialContent
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, RECAF and CEI
17 Nov, 2021 FinancialContent
Why Amarin Stock Crushed the Market on Tuesday
16 Nov, 2021 FinancialContent

An activist investor revealed that it held a small stake in the company.

Amarin Posts Encouraging Vascepa Data In Patients With Peripheral Artery Disease
16 Nov, 2021 FinancialContent

Amarin Corporation plc(NASDAQ: AMRN)reported new datafor Vascepa/Vazkepa (icosapent ethyl) at the American Heart ...

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
16 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports ...

SHAREHOLDER ALERT: AMRN ONTF NVAX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
16 Nov, 2021 FinancialContent
SHAREHOLDER ALERT: BMRN AMRN SNAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
15 Nov, 2021 FinancialContent
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
14 Nov, 2021 FinancialContent

Biotech stocks declined for the second straight week amid a broader market pullback, along withearnings news from small- and ...

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, RECAF and SNAP
14 Nov, 2021 FinancialContent
CLASS ACTION UPDATE for HNST, AMRN and HMLP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
12 Nov, 2021 FinancialContent
December 31st Options Now Available For Amarin
11 Nov, 2021 FinancialContent

Investors in Amarin Corp plc (AMRN) saw new options become available today, for the December 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for the new December 31st contracts and identified one put and one call contract of particular interest.

CLASS ACTION UPDATE for NNOX, AMRN and RECAF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
11 Nov, 2021 FinancialContent

Amarin Corporation plc (AMRN) is a NASDAQ Common Stock listed in , ,

970x250